# PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER AND OTHER INDICATIONS  INDICATIONS

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2024 · $375,416

## Abstract

The test agent is being considered for development of an anticancer therapeutic.

## Key facts

- **NIH application ID:** 11124482
- **Project number:** 75N91022C00010-P00009-9999-2
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** DAVID L. MCCORMICK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $375,416
- **Award type:** —
- **Project period:** 2022-04-01 → 2025-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11124482

## Citation

> US National Institutes of Health, RePORTER application 11124482, PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER AND OTHER INDICATIONS  INDICATIONS (75N91022C00010-P00009-9999-2). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11124482. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*